Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, FL 33101, USA.
Vaccine. 2010 Nov 29;28(51):8077-84. doi: 10.1016/j.vaccine.2010.10.023. Epub 2010 Oct 23.
We have evaluated the serum response to seasonal influenza vaccination in subjects of different ages and associated this with the specific B cell response to the vaccine in vitro. Although the serum response has previously been shown to decrease with age, this has largely been associated to decreased T cell functions. Our results show that in response to the vaccine, the specific response of B cells in vitro, as measured by AID (activation-induced cytidine deaminase), the in vivo serum HI (hemagglutination inhibition) response, and the in vivo generation of switch memory B cells are decreased with age, as evaluated in the same subjects. This is the first report to demonstrate that intrinsic B cell defects with age contribute to reduced antibody responses to the influenza vaccine. The level of AID in response to CpG before vaccination can also predict the robustness of the vaccine response. These results could contribute to developing more effective vaccines to protect the elderly as well as identifying those most at risk.
我们评估了不同年龄组人群接种季节性流感疫苗后的血清反应,并将其与体外疫苗的特异性 B 细胞反应相关联。尽管先前的研究表明血清反应随年龄增长而降低,但这主要与 T 细胞功能下降有关。我们的结果表明,与疫苗接种一样,体外测量的 B 细胞特异性反应(通过 AID 评估)、体内血清 HI(血凝抑制)反应以及体内转换记忆 B 细胞的生成,在同一批受试者中也会随年龄增长而降低。这是首个证明内在 B 细胞缺陷随年龄增长导致对流感疫苗抗体反应降低的报告。接种疫苗前对 CpG 的 AID 反应水平也可以预测疫苗反应的稳健性。这些结果有助于开发更有效的疫苗来保护老年人,并确定最易受感染的人群。